» Articles » PMID: 1330633

The Effects of Flosequinan on Endothelin-1-induced Changes in Inositol 1,4,5-trisphosphate Levels and Protein Kinase C Activity in Rat Aorta

Overview
Journal Eur J Pharmacol
Specialty Pharmacology
Date 1992 Jul 1
PMID 1330633
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

In rat aorta endothelin-1 (10(-8) M) induces significant increases in inositol 1,4,5-trisphosphate (IP3) levels after a 30 s exposure. An increase in particulate protein kinase C activity is also observed at 30 s with a second peak of activity occurring after 10 min. Flosequinan, at concentrations of 10(-6) M or greater, inhibits these endothelin-1-induced changes in both IP3 and particulate protein kinase C activity in the absence of changes in either cyclic GMP or cyclic AMP. It is likely therefore that flosequinan inhibits the transduction mechanisms between the endothelin-1 receptor and hydrolysis of phosphatidylinositol 4,5-bisphosphate, possibly at the level of a G-protein. These results provide a mechanism to explain the vasodilator effects of flosequinan observed in vitro.

Citing Articles

Poster communications.

Br J Pharmacol. 2008; 109(Suppl):67P-142P.

PMID: 19108269 PMC: 2175552.


Lack of pharmacodynamic interactions between acute dose flosequinan and xamoterol. A pilot study in healthy subjects.

Ng H, Walley T, Tsao Y, Breckenridge A Eur J Clin Pharmacol. 1994; 46(4):361-5.

PMID: 7957523 DOI: 10.1007/BF00194406.